Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13415
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBellomo, Rinaldoen
dc.date.accessioned2015-05-16T03:15:42Z
dc.date.available2015-05-16T03:15:42Z
dc.date.issued1995-11-01en
dc.identifier.citationNew Horizons (baltimore, Md.); 3(4): 732-7en
dc.identifier.govdoc8574604en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/13415en
dc.description.abstractContinuous hemofiltration was first described as a new form of renal replacement for critically ill patients in the late 1970s. Since then, it has undergone remarkable technical and conceptual modifications and has become a widely used form of dialytic therapy in the ICU. More recent insights into the pathogenesis of sepsis and the role of soluble molecules in the mediation of organ injury during septic shock have led to a resurgence of the concept of blood purification during life-threatening infection. Recent studies have confirmed that cytokine extraction occurs in vivo in humans during continuous hemofiltration and that other smaller, potentially noxious molecules such as platelet-activating factor, complement factors C5a and C3a, and thromboxane are also removed from the circulation of septic patients or animals. Experimental studies have shown that continuous hemofiltration has beneficial hemodynamic effects in septic animals and that such effects may correlate with the intensity of ultrafiltration. Cardiac function also appears to improve and myocardial depressant factors are removed from the circulation. Continuous hemofiltration offers some promise as an adjunctive form of treatment in severe sepsis.en
dc.language.isoenen
dc.subject.otherAnimalsen
dc.subject.otherCytokines.immunologyen
dc.subject.otherHemodynamicsen
dc.subject.otherHemofiltration.methods.trendsen
dc.subject.otherHumansen
dc.subject.otherSepsis.immunology.physiopathology.therapyen
dc.subject.otherTreatment Outcomeen
dc.titleContinuous hemofiltration as blood purification in sepsis.en
dc.typeJournal Articleen
dc.identifier.journaltitleNew horizons (Baltimore, Md.)en
dc.identifier.affiliationDepartment of Anaesthesia and Intensive Care, Austin Hospital, Melbourne, Victoria, Australiaen
dc.description.pages732-7en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/8574604en
dc.type.austinJournal Articleen
local.name.researcherBellomo, Rinaldo
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.grantfulltextnone-
crisitem.author.deptIntensive Care-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

18
checked on Mar 1, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.